CVE-2021-43834
CRITICALDescription
eLabFTW is an electronic lab notebook manager for research teams. In versions prior to 4.2.0 there is a vulnerability which allows an attacker to authenticate as an existing user, if that user was created using a single sign-on authentication option such as LDAP or SAML. It impacts instances where LDAP or SAML is used for authentication instead of the (default) local password mechanism. Users should upgrade to at least version 4.2.0.
How to fix
Remediation is compiled from vendor and distribution security advisories. Always confirm against the linked source for your exact version and platform.
CVSS v3 Vector
Exploitability
Impact
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Exploit Intelligence
Moderate risk: more likely to be exploited than 58% of all known CVEs.
References
Related Vulnerabilities
Other CWE-287 (Improper Authentication) vulnerabilities, ordered by exploit likelihood. View all
| CVE | Severity | CVSS | EPSS | Exploited | Fix |
|---|---|---|---|---|---|
| CVE-2023-35082 | Critical | 9.8 | 100% | KEV + Ransom | Fix |
| CVE-2023-35078 | Critical | 9.8 | 100% | KEV + Ransom | Fix |
| CVE-2017-7921 | Critical | 9.8 | 100% | KEV | - |
| CVE-2024-7593 | Critical | 9.8 | 100% | KEV | - |
| CVE-2023-46805 | High | 8.2 | 100% | KEV + Ransom | - |
| CVE-2022-40684 | Critical | 9.8 | 100% | KEV + Ransom | Fix |
Embed a live status badge for CVE-2021-43834
Markdown
[](https://tridentstack.com/cve/CVE-2021-43834)HTML
<a href="https://tridentstack.com/cve/CVE-2021-43834"><img src="https://tridentstack.com/cve/badge/CVE-2021-43834.svg" alt="CVE-2021-43834"></a>Find and fix vulnerabilities across your fleet
TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.
Start freeThis product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.